Climb Bio, Inc. (CLYM) vs Verastem, Inc. (VSTM)
Climb Bio, Inc. and Verastem, Inc. are both Biotechnology companies. Climb Bio, Inc. and Verastem, Inc. are of similar size ($694.6M and $682.9M). Climb Bio, Inc. has the higher net margin (0.00% vs −231.6%) and the lower return on invested capital (−71.7% vs 0.00%). Across the 13 metrics below, Climb Bio, Inc. leads on 11 and Verastem, Inc. on 2.
Valuation
Profitability
| Metric | CLYM | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 86.35% | 65.16% |
| Operating margin | 0.00% | (182.57%) | 0.00% |
| Net margin | 0.00% | (231.59%) | 0.00% |
| Free cash flow margin | 0.00% | (185.31%) | 0.00% |
| Return on equity | (27.10%) | (471.16%) | (57.72%) |
| Return on assets | (26.27%) | (100.65%) | (49.22%) |
| Return on invested capital | (71.73%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack